UW TechTransfer Invention Licensing Materials Transfer Agreement (Not-for- profit Institutions)Materials Transfer Agreement • September 15th, 2020
Thank you for downloading this Material Transfer Agreement (MTA) from UW TechTransfer Invention Licensing. To process your request, please follow the steps below. If you have any questions about this process, please send an email to mta-group@u.washington.edu and someone will respond to your inquiry.
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • January 6th, 2023
[ ] (“Sample Provider”), and is effective as of the date of the signature last signed below (“Effective Date”). Verily and Sample Provider are referred to herein individually as a “Party” and collectively as the “Parties.”
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • September 13th, 2022 • District of Columbia
(Complete all contact and external party information for those individuals directly involved in the transfer of materials [e.g., PIs])
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • May 5th, 2020
This document constitutes an agreement between Mount Sinai Hospital and University of Washington (“Institution”) for the distribution of the G4 and C57 BL/6 mouse embryonic stem cell lines to scientists at Institution who agree to be bound by the terms of this Agreement (“Recipient Scientist”). Mount Sinai Hospital is pleased to be able to provide research materials produced in the laboratory of Dr Andras Nagy subject to the following terms and conditions:
Materials Transfer Agreement Conditions for the transfer of biomaterials (specimens, tissues, skeletons, images and associated data) from the SAIAB collections.Materials Transfer Agreement • February 7th, 2024
The South African Institute for Aquatic Biodiversity (SAIAB) is a National Facility of the National Research Foundation of South Africa. SAIAB has a growing collection of biomaterials (specimens, tissues, skeletons and associated data) and which are available to bona fide researchers. SAIAB has a generally open access policy to the loaning of biomaterials and data. We do, however, apply certain rules to loan requests in order to ensure materials are used optimally and are not wasted. There are also certain logistical constraints which may also affect loan approvals e.g. only SAIAB technicians will sub-sample SAIAB biomaterials, and therefore requests for outgroup material or a series of small transfers with regular progress reports would be favoured rather than single large transfers. For very limited or valuable tissue samples, DNA extractions can be made available, but the costs must be borne by the requesting researcher or institution.
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • June 18th, 2007
This Material Transfer Agreement (“MTA”) is by and between [Company Name], having its principal place of business at , and The National Institute of Standards and Technology (“Recipient”), having its principal place of business at Systems and Network Security Group, Computer Security Division, Information Technology Laboratory, Gaithersburg, Maryland 20899. This Agreement is entered into by NIST pursuant to the authorities granted under Title 15 United States Code section 3710(a).
ContractMaterials Transfer Agreement • May 5th, 2020 • Maryland
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. TABLE OF CONTENTS
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • June 8th, 2009
This document constitutes an agreement between Mount Sinai Hospital (hereinafter referred to as “Provider”) and the recipient scientist and institution for the distribution of research materials produced jointly in the laboratory of Mount Sinai Hospital. Provider is pleased to be able to provide the research materials subject to the following terms and conditions:
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • September 15th, 2022 • District of Columbia
☐ A copy of the current ToxCast chemical library, or subset, consisting of chemical samples prepared as solution in dimethyl sulfoxide at a concentration of 20 millimolar. Additional chemicals may be provided in the future concurrent with expansion of the ToxCast chemical library.
Materials Transfer Agreement Governing the Transfer of Samples and Biological MaterialsMaterials Transfer Agreement • August 13th, 2020
The purpose of this letter is to provide a record of the biological material transfer from the PROVIDER SCIENTIST (identified below) and the RECIPIENT SCIENTIST (identified below) to abide by all terms and conditions of the Nigerian National Code for Health Research Ethics and to certify that the RECIPIENT (identified below) organization has accepted and signed an unmodified copy of this agreement. The RECIPIENT organization's Authorized Official will also sign this letter if the RECIPIENT SCIENTIST is not authorized to certify on behalf of the RECIPIENT organization. The RECIPIENT SCIENTIST (and the Authorized Official of RECIPIENT, if necessary) should sign both copies of this letter and return one signed copy to the PROVIDER. The PROVIDER SCIENTIST will forward a copy of this agreement to the National Health Research Ethics Committee of Nigeria after which approval for proposed research will be given by the Institutional Health Research Ethics Committee (HREC). The PROVIDER SCIENTIS
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • June 25th, 2013
The UNIVERSITY OF THE PHILIPPINES, the National University of the Philippines, a public and secular institution of higher learning, created by virtue of Act No. 1870, as amended and reorganized and operating by virtue of Republic Act No. 9500, through its constituent university, the UNIVERSITY OF THE PHILIPPINES _______________, with principal office address at the ___________________________, and represented herein by its Chancellor, ________________________, and hereinafter referred to as “UP”,
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • January 6th, 2023
⌧ A copy of the current ToxCast chemical library, or subset, consisting of chemical samples prepared as solution in dimethyl sulfoxide at a concentration of 20 millimolar. Additional chemicals may be provided in the future concurrent with expansion of the ToxCast chemical library.
MATERIALS TRANSFER AGREEMENT FOR UNIVERSITIES, GOVERNMENTAL LABORATORIES AND NON-PROFIT INSTITUTIONSMaterials Transfer Agreement • January 19th, 2006
This document constitutes an agreement between Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5 and the recipient scientist and institution for the distribution and use of research materials.
ContractMaterials Transfer Agreement • July 29th, 2021 • Massachusetts
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • August 8th, 2022
☐ A copy of the current ToxCast chemical library, or subset, consisting of chemical samples prepared as solution in dimethyl sulfoxide at a concentration of 20 millimolar. Additional chemicals may be provided in the future concurrent with expansion of the ToxCast chemical library.
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • March 26th, 2021 • District of Columbia
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • September 17th, 2020
THIS MATERIALS TRANSFER AGREEMENT (“Agreement”), made by and between _____________________(hereinafter: “Transferee”) and Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center, with offices at Weizman 6, st. Tel Aviv Israel (hereinafter: “Transferor”), shall govern the terms and conditions of the transfer of tangible samples and/or biological materials by . This Agreement is being made effective as of the date of the signature by or on behalf of _____________________ and Transferor as appears on the signature page hereof (the “Effective Date”).
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • March 1st, 2012
The Faculty of Medicine, Diponegoro University, an Indonesian Research institution existing under the laws of the Republic of Indonesia, having its registered office at Jl. Dr. Sutomo No. 18, Semarang, Central Java Province, Indonesia (hereinafter referred to as “First Party”), represented by Prof. Sultana M. H. Faradz, MD, PhD, in this matter acting in her capacity as the Director of The Center For Biomedical Research, Faculty of Medicine, Diponegoro University.
MATERIALS TRANSFER AGREEMENT Suggested proforma for the public exchange of materials and/or data resulting from the BBSRC funded LoLa WISP Project.Materials Transfer Agreement • May 11th, 2012
This Material Transfer Agreement does not imply any direct or indirect license or warranty whatsoever with regards to the Material and use thereof nor does it guarantee not to infringe on any rights or claims of third parties with regards to the Material or the Material’s suitability, novelty or safety for any purpose whatsoever. Recipient is solely responsible for their use of such Material.
MATERIALS TRANSFER AGREEMENT LIMITED USE OF PRODUCTSMaterials Transfer Agreement • March 30th, 2021 • London
This Materials Transfer Agreement (“Agreement”), effective , (“Effective Date”) is between 4BASEBIO SLU., a Spanish company, having an office Faraday 7, Lab 2.04, 28.049, Madrid (Spain) (“Provider”) and , having offices at (“Recipient”).
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations
This Agreement is among Advanced Cell Technology, Inc. (“ACT”), and Charlotte Farin, Ph.D. and Peter Farin, D.V.M., Ph.D. (Dr. Charlotte Farin and Dr. Peter Farin collectively referred to herein as “Researcher”), professors at North Carolina State University in Raleigh, North Carolina (“The Institution”). The Institution and the Researcher are collectively referred to in this Agreement as the “Recipients.”
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • October 20th, 2021
☐ A copy of the current ToxCast chemical library, or subset, consisting of chemical samples prepared as solution in dimethyl sulfoxide at a concentration of 20 millimolar. Additional chemicals may be provided in the future concurrent with expansion of the ToxCast chemical library.
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • October 18th, 2011 • Tennessee
This Agreement is made and entered into as of , 2011 (the "Effective Date"), by and between The University of Tennessee, having a place of business at ("UNIVERSITY"), The University of Tennessee Research Foundation, having a place of business at 600 Henley Street, Conference Center Suite 211, Knoxville, Tennessee 37996-1527 ("UTRF") and
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • September 13th, 2020
THIS AGREEMENT entered into on the ____ day of ____, 2018 (“Effective Date”) by and between The Royal Childrens Hospital (RCH) ABN 35655720546 and ______("Recipient").
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • July 9th, 2015 • District of Columbia
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations
This Agreement is among Advanced Cell Technology, Inc. (“ACT”), B.C. Cancer Research Centre (“The Institution”) and Dr. Peter Lansdorp (“Researcher”). The Institution and the Researcher are collectively referred to in this Agreement as the “Recipients.”
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • May 13th, 2021 • District of Columbia
samples prepared as solution in dimethyl sulfoxide at a concentration of 20 millimolar. Additional chemicals may be provided in the future concurrent with expansion of the ToxCast chemical library.
UNIVERSITY OF COLORADO MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • May 15th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
This is an Agreement, dated October 14, 2005 (the “Effective Date”), between the Regents of the University of Colorado, a body corporate, contracting on behalf of the University of Colorado Health Sciences Center (“UCHSC”), and ARCA Discovery, Inc., a Delaware corporation with a principal place of business located at 1400 16th Street, Suite 220, Denver, CO 80202 (“Recipient”).
Materials Transfer AgreementMaterials Transfer Agreement • February 17th, 2011
This Agreement, between _____________ (“Provider”), and ______________, an academic institution located at _______________ (“Recipient”), governs an arrangement whereby Provider makes available to Recipient the following biological Materials with a specific mutation in a specified portion of a gene (the “Requested Mutation”), ___________________for use in the research project devoted to characterize and investigate ____________________________________
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • September 20th, 2022
The North Carolina Human Health Exposure Analysis Resource Core, based at RTI International, with a collaborating laboratory at the University of North Carolina -Chapel Hill.
MATERIALS TRANSFER AGREEMENT (MTA)Materials Transfer Agreement • August 19th, 2021
This agreement (“Agreement”) concerns the distribution and use of certain biological materials and is made among (“INSTITUTION”) and Public Health Institute (“PHI”), on behalf of Children’s Oncology Group (“COG”). INSTITUTION, PHI and COG are individually known as Party, and collectively, as the “Parties”.
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • February 8th, 2008 • Alynx, Co. • Blank checks • Pennsylvania
This Materials Transfer Agreement (the “Agreement”), effective the 28th day of March, 2007 (“Effective Date”), is entered into by and between Kensey Nash Corporation, a Delaware corporation having its principal place of business at 735 Pennsylvania Drive, Exton, Pennsylvania 19341 (hereinafter “KNC”), and MiMedx, having offices at 1234 Airport Road, Destin, Florida 32541 (hereinafter “MiMedx”).
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • October 15th, 2020 • California
This agreement ("AGREEMENT") is effective on the date of the last authorized signatures of the parties ("Effective Date"). The parties in this AGREEMENT are <fill in: INSTITUTION NAME>, (“RECIPIENT”), a non-profit academic institution located at <fill in: INSTITUTION ADDRESS>, and The Regents of the University of California located at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200 ("UNIVERSITY"), represented by its San Diego campus located at the University of California San Diego, Technology Transfer Office, 9500 Gilman Drive, La Jolla, California 92093‑0910 ("UCSD").
Materials Transfer AgreementMaterials Transfer Agreement • July 1st, 2024
Karolinska Institutet, Department of [insert], Sweden, agrees to provide [insert name of university/company and (organisation number), country], with material subject to the following terms and conditions.
MATERIALS TRANSFER AGREEMENTMaterials Transfer Agreement • February 21st, 2013
The PROVIDER SCIENTIST (identified below) and the RECIPIENT SCIENTIST (identified below) desire to enter into a research collaboration, in the furtherance of which the PROVIDER SCIENTIST will be providing ORIGINAL MATERIALS, and information about them, to the RECIPIENT SCIENTIST. The parties agree by signature below that this Agreement constitutes a “joint research agreement” as that term is defined by the Cooperative Research and Technology Enhancement Act of 2004, 35 U.S.C. § 103(c)(3). In the event of any Inventions, the Parties will reasonably cooperate in invoking the CREATE Act and its companion regulations to overcome an obviousness rejection of a patent application.
